Blood test measuring epigenetic instability aids in detecting early-stage cancers

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...

Protagonist Therapeutics: Assessing The 2026 Upside For Icotrokinra And Rusfertide

Protagonist (PTGX) is a high-conviction buy: late-stage icotrokinra & rusfertide near 2026 milestones, strong cash runway. Read more here.
AFP

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)

OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif. Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the ...
MedPage Today on MSNOpinion

Let's rethink how EHRs flag 'abnormal' lab results

Portal designs often amplify alarm rather than offering context ...
DogsBestLife.com on MSN

How to read your dog’s blood work like a veterinarian: Simple steps

Learn how to understand dog blood work with this comprehensive guide. Decode CBC, chemistry panels, liver, and kidney values.